Dry Eye Syndromes clinical trials
The registry lists 1,367 studies for Dry Eye Syndromes across more than 10 countries. 208 are recruiting or about to start. 1,156 of them are mainly about Dry Eye Syndromes (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 3 narrower conditions too, such as Sjogren's Syndrome: 1,667 studies, 295 open.
ClinicalTrials.gov finds 1,718 studies for Dry Eye Syndromes. How that becomes 1,364 here
This page counts the studies the registry files under Dry Eye Syndromes, and those it files under no condition that list Dry Eye Syndromesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 1,718Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −294Filed under a narrower condition, counted on its own pageSjogren's Syndrome 267 · Keratoconjunctivitis Sicca 17 · Xerophthalmia 8
- −2List Dry Eye Syndromes as a condition, but the registry did not file them under itMost often written as “Moderate to Severe Dry Eye Syndrome” (1) and “Inflammatory Dry Eye Disease” (1). The registry filed them under other conditions only, most often Lymphoma, Follicular (1) and Hematologic Neoplasms (1).
- −58Match it another way15 name it in the title and 43 by a synonym or other text the search reads.
- 1,364The count on this page9 of them list Dry Eye Syndromes in their own words; the registry filed them under no condition.
Get an email when these change. Save the Dry Eye Syndromes studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Alcon Research (85) · Allergan (42) · Medical University of Vienna (24) · Bausch & Lomb Incorporated (23) · Singapore National Eye Centre (20) · He Eye Hospital (17) · Innovative Medical (15) · University of Alabama at Birmingham (15)
What is being tested here
Drugs under test in Dry Eye Syndromes studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Calcineurin inhibitors 5 open · Corticosteroids 1 open · Antihistamines 8 · Tyrosine kinase inhibitors (TKIs) 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026A Clinical Study Evaluating Licaminlimab for Dry Eye Disease · Phase 3 · Oculis
- Apr 2027Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease · Phase 3 · VivaVision Biotech, Inc
- Nov 2027Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye · Phase 3 · Cambium Bio Limited
- Nov 2026A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease · BRIM Biotechnology Inc.
- Nov 2026Association Between Periodontitis and Dry Eye Disease: A Cross-Sectional Study · University of Sulaimani
- Nov 2026A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease · Dr. Gerhard Mann chem.-pharm. Fabrik GmbH
- Nov 2026A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK · Vance Thompson Vision
- Nov 2026Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction · Varol TUNALI
- Nov 2026Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT) · Center for Sight Las Vegas
- Nov 2026Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease · The First Affiliated Hospital of Xiamen University
Who these studies take
Of the 116 Dry Eye Syndromes studies recruiting now, 73 (63%) set no upper age limit and 24 (21%) stop at 75 or younger. 7 (6%) take children under 18. 3 (3%) are for women only and 0 (0%) for men only; 29 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 6 (5%) | 6 (5%) |
| 18 | 87 (75%) | 87 (75%) |
| 30 | 109 (94%) | 106 (91%) |
| 40 | 108 (93%) | 106 (91%) |
| 50 | 109 (94%) | 108 (93%) |
| 65 | 105 (91%) | 104 (90%) |
| 75 | 99 (85%) | 99 (85%) |
| 85 | 84 (72%) | 84 (72%) |
Across all 1,367 studies, recruiting or not: 19% stop at 75 or younger and 12% at 65; 5% take children; 2% are for women only and <1% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Dry Eye Syndromes studies take
Of 112 phase 4 interventional studies under Dry Eye Syndromes, half reached primary completion within 12 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 6 mo4–13 · 34 studies | — | — |
| Phase 1/2 | 14 mo7–24 · 21 studies | — | — |
| Phase 2 | 7 mo5–12 · 91 studies | 7 mo4–11 · 75 studies | — |
| Phase 2/3 | 11 mo6–18 · 15 studies | — | — |
| Phase 3 | 10 mo7–15 · 96 studies | 9 mo6–15 · 81 studies | — |
| Phase 4 | 12 mo5–23 · 112 studies | 8 mo4–15 · 28 studies | 13 mo7–28 · 84 studies |
| Interventional, no phase | 10 mo4–18 · 312 studies | 9 mo4–13 · 113 studies | 12 mo5–25 · 199 studies |
| Observational | 12 mo5–64 · 69 studies | — | 21 mo9–64 · 53 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 14, 2026.
Started recruiting2
- BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialNov 10, 2026NCT07778888
- Phase III Study of OT202 in Treating Moderate to Severe Dry EyeOct 15, 2026NCT07740564
Results posted3
- Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye DiseaseNov 10, 2026NCT04413279
- Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host DiseaseOct 28, 2026NCT04313725
- Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye DiseaseOct 27, 2026NCT04413253
Newly registered14
- Decentralized Dry Eye Study, Planning & FeasibilityNov 12, 2026NCT07933874
- A Multi Center Evaluation of TearCare on Surgical Measurements Before Cataract SurgeryNov 10, 2026NCT07928986
- Effectiveness Study of TRYPTYR in Dry Eye DiseaseNov 9, 2026NCT07926594
- Vitamin B Complex as Adjunct Therapy for Moderate-to-Severe Dry Eye DiseaseNov 5, 2026NCT07919223
- LacriFill Canalicular Occlusion for Dry Eye After LASIKNov 3, 2026NCT07911930
Show 9 moreShow fewer
- a Novel siRNA Eyedrops for DED TreatmentNov 2, 2026NCT07908251
- A Clinical Study to Evaluate the Safety and Effectiveness of MSCohi-O Lens in the Treatment of Immune-related Ocular Surface Diseases.Oct 29, 2026NCT07902687
- Treating Contact Lens Discomfort With Cyclosporine 0.1% Ophthalmic SolutionOct 29, 2026NCT07904728
- Evaporative Dry EyeOct 28, 2026NCT07901647
- 20-20-20 Rule Plus Artificial Tears for Dry EyeOct 27, 2026NCT07896395
- Performance Evaluation of the OCUTOP Hand-held Corneal TopographerOct 26, 2026NCT07895849
- Cooling Eyedrops for Dry EyeOct 22, 2026NCT07888452
- Association Between Periodontitis and Dry Eye Disease: A Cross-Sectional StudyOct 14, 2026NCT07873697
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesOct 14, 2026NCT07873931
Studies
Recruiting first, then most recently updated. Showing 50 of 1,367. Browse all 1,367 → or search them.
- Decentralized Dry Eye Study, Planning & FeasibilityNot yet recruitingNCT079338741 country
- UNITY DX Cornea StudyRecruitingNCT077687351 country
- Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease ManagementRecruitingNCT07842536Not applicable1 country
- A Multi Center Evaluation of TearCare on Surgical Measurements Before Cataract SurgeryRecruitingNCT079289861 country
- Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland DysfunctionEnrolling by invitationNCT07453212Not applicable1 country
- BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialRecruitingNCT07778888Phase 21 country
- Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®Not yet recruitingNCT06375343Phase 1
- Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGDRecruitingNCT06220474Not applicable1 country
- Effectiveness Study of TRYPTYR in Dry Eye DiseaseRecruitingNCT079265941 country
- 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal KeratoconjunctivitisRecruitingNCT06903884Phase 31 country
- Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional TreatmentsNot yet recruitingNCT06905834Phase 2
- LacriFill Canalicular Occlusion for Dry Eye After LASIKNot yet recruitingNCT07911930Not applicable1 country
- a Novel siRNA Eyedrops for DED TreatmentNot yet recruitingNCT07908251Early Phase 1
- TearCare in Young AdultsNot yet recruitingNCT07579156Not applicable1 country
- Treating Contact Lens Discomfort With Cyclosporine 0.1% Ophthalmic SolutionRecruitingNCT07904728Not applicable1 country
- A Clinical Study to Evaluate the Safety and Effectiveness of MSCohi-O Lens in the Treatment of Immune-related Ocular Surface Diseases.Not yet recruitingNCT07902687Phase 1
- Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye DiseaseRecruitingNCT05865379Not applicable2 countries
- A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASERecruitingNCT07118241Phase 21 country
- Evaporative Dry EyeNot yet recruitingNCT07901647Phase 41 country
- Performance Evaluation of the OCUTOP Hand-held Corneal TopographerNot yet recruitingNCT07895849Not applicable1 country
- Cooling Eyedrops for Dry EyeNot yet recruitingNCT07888452Phase 41 country
- A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)RecruitingNCT07118254Phase 21 country
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseaseRecruitingNCT07503886Phase 21 country
- Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.RecruitingNCT07571330Not applicable1 country
- Phase III Study of OT202 in Treating Moderate to Severe Dry EyeRecruitingNCT07740564Phase 31 country
- Association Between Periodontitis and Dry Eye Disease: A Cross-Sectional StudyRecruitingNCT078736971 country
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesNot yet recruitingNCT07873931Phase 16 countries
- Contact Lens-Wearing Dry Eye Subjects Who Are Treated With Acoltremon 0.003%Not yet recruitingNCT07848373Phase 4
- Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic Corneal PainNot yet recruitingNCT07849803Phase 41 country
- Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Moderate to Severe Primary Sjögren's SyndromeNot yet recruitingNCT07852234Phase 21 country
- A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye DiseaseRecruitingNCT07593885Not applicable1 country
- Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye DiseaseRecruitingNCT05865457Not applicable2 countries
- Study of Eye Fatigue From Digital Screens and Its Impact on Visual Performance in People With Normal Vision and Myopia, With and Without Dry Eye Symptoms and SignsNot yet recruitingNCT07844408Not applicable1 country
- Switching From Preserved Glaucoma Therapy to Preservative-Free ZOLYMBUSNot yet recruitingNCT07845357Phase 4
- Ocular Surface Disease in Glaucoma Patients on Long-Term TherapyNot yet recruitingNCT07841912
- Evaluation of LacrifillRecruitingNCT07796178Phase 41 country
- A Study of Full-Spectrum Screen Lighting for Reducing Screen-Related Eye Fatigue and Dry EyeNot yet recruitingNCT07706231Not applicable1 country
- Clinical Applications of Advanced Ophthalmic ImagingRecruitingNCT03135327Not applicable1 country
- BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture ChamberRecruitingNCT07430735Not applicable1 country
- Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic PatientsNot yet recruitingNCT07810569
- Temporary Tear Duct Filling With Hyaluronic Acid Gel and Assessment of Dry Eye Disease (DED) After Bilateral Cataract SurgeryNot yet recruitingNCT07809022Phase 41 country
- BL-RX01-TFSTAB-1402RecruitingNCT07790211Phase 41 country
- Autologous Plasma Rich in Growth Factors for Severe Dry Eye DiseaseNot yet recruitingNCT07773740Not applicable
- A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and DiseasesRecruitingNCT077808901 country
- Study of 5% VVN001 Ophthalmic Solution in Dry Eye DiseaseRecruitingNCT06360133Phase 31 country
- Long-term Effects of Acoltremon vs. Control in Dry Eye DiseaseRecruitingNCT076596261 country
- POST CATARACT SURGERY DRY EYE DISEASENot yet recruitingNCT07715266Not applicable1 country
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)RecruitingNCT06977724Phase 13 countries
- The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative FreeRecruitingNCT07745062Phase 41 country
- Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mgRecruitingNCT07705893Not applicable1 country